Discovering Therapeutics With AI

insitro combines high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapeutics.

Discover Transformative Therapeutics and Innovative Discoveries

insitro combines automated high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapeutics.

Pioneering AI-Driven Therapeutics

We combine automated high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapies.

Automated lab instrument processing samples under green light.

Cell Biology

Automated high-throughput cellular assays for deep biological insights.

Hands pointing at a digital screen with data visualizations.

Human Genetics

Leveraging vast genetic data to uncover novel disease targets.

Scientific laboratory featuring rows of large water-filled glass tanks.

Machine Learning

Advanced algorithms designed to model complex biological systems.

Pioneering Therapeutics Through AI and Biology

Founded in 2018 by Daphne Koller and headquartered in South San Francisco, insitro integrates automated high-throughput cell biology, human genetics, and machine learning. Our mission is to discover causal disease drivers and design targeted therapeutics to transform patient care.

Digital screens display DNA helix and genetic data in a modern lab.

Our Process

We combine automated high-throughput cell biology, human genetics, and machine learning to drive discovery.

Robotic arm works with scientific instruments on a lab bench.

Cellular Biology

Automated high-throughput cell biology generates robust functional data at scale.

Human Genetics

Advanced analytics uncover causal disease drivers from complex genomic datasets.

Machine Learning

Predictive models are trained to design targeted therapeutics effectively.

Accelerating Drug Discovery Through Machine Learning

Discover our core pillars combining advanced cellular biology and artificial intelligence.

2018

Founded Year

Established in South San Francisco to transform therapeutic development.

100

Cell Models

Automated high-throughput platforms generating rich biological data.

50

Disease Drivers

Identifying novel targets for truly transformative targeted medicines.